TC
TECH icon

TFS Capital’s Bio-Techne TECH Stock Holding History

TFS Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,860
Closed -$281K – 1573
2013
Q4 		$281K Sell
11,860
-97,324
-89% -$2.11M 0.01% 1124
2013
Q3 		$2.19M Sell
109,184
-258,104
-70% -$4.9M 0.1% 296
2013
Q2 		$6.34M Buy
+367,288
New +$6.1M 0.27% 66

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

TFS Capital's TECH Position: Q1 2014 in Review

TFS Capital sold out of Bio-Techne (TECH) in Q1 2014, closing a stake of 11,860 shares — an estimated $281K sold.

TFS Capital first reported a position in TECH in Q2 2013 and held it in 3 quarters. The position peaked at $6.34M in Q2 2013. 240 funds tracked by Wall St. Rank hold TECH as of Q1 2014.

  • TFS Capital reported no remaining Bio-Techne position as of Q1 2014 after selling out during the quarter.
  • TFS Capital sold 11,860 Bio-Techne shares in Q1 2014, an estimated $281K.
  • TFS Capital first reported a position in Bio-Techne in Q2 2013 and held it in 3 quarters.
  • TFS Capital's Bio-Techne position peaked at $6.34M in Q2 2013.
  • 240 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2014.

Based on TFS Capital's 13F filing for Q1 2014, filed 5 May 2014.